ArticleScientific reports2025
Enhancement of wheat bread quality using xylanase cellulase from gamma radiated Trichoderma afroharzianum mutant.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the production and application of a xylanase-cellulase enzyme complex derived from a gamma radiation-induced mutant strain of Trichoderma afroharzianum NAS107-M82 to enhance wheat bread quality. The mutant strain exhibited significantly elevated extracellular enzyme activities, with xylanase and cellulase levels approximately 3.3 and 1.7 times higher than those of the wild type, respectively, indicating superior lignocellulosic substrate hydrolysis. The enzyme complex, optimized at 45 °C and pH 5.0 for xylanase and 50 °C and pH 4.8 for cellulase, contained key isoforms including Xyl I, Cel12A, and Xyl IV, which acted synergistically to degrade arabinoxylan and cellulose components in wheat flour. Rheological assessments via farinograph and extensograph demonstrated that supplementing dough with 300 to 600 U/kg of the enzyme complex reduced water absorption, and decreased dough development and stability times, while improving dough extensibility and mixing tolerance. These changes produced a softer, more manageable dough with enhanced fermentation performance. Bread made with enzyme treatment showed significantly improved specific volume, crumb porosity, and sensory properties such as crust color, texture, aroma, and taste compared to control and commercially improver-enriched breads. Notably, breads containing 300 U/kg enzyme exhibited enhanced softness and delayed staling over seven days, attributed to increased moisture retention and modified crumb structure. These results suggest that the gamma radiation-induced mutant strain is a promising source of industrially valuable xylanase-cellulase enzymes for bakery applications. Overall, targeted enzymatic treatment of wheat flour represents a viable strategy to improve bread quality, shelf life, and consumer acceptability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.